skip to content

Centre for Law, Medicine and Life Sciences

Faculty of Law

On 8 April 2021, Dr John Liddicoat (LML Senior Research Associate) participated in a panel discussion on novelty and second medical use patents. 

Hosted by Life Sciences Intellectual Property Review, ‘Why patent protection is Key to Commercialising Repurposed Drugs’ was a roundtable event which sought to discuss how stakeholders might use patents maximise their returns on repurposed drugs. Discussion focused on overcoming three barriers to patent protection in particular: the issue of novelty; obviousness rejections and the use of “unexpected results; and the distinctions between “composition of matter” patents and “method of use” patents.

Further information can be found here.